Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2023-08-03 Board/Management Inform…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding a change in senior management, specifically the resignation of a senior management personnel. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and provides details about the resignation and the process to fill the vacancy. There are no financial statements, earnings data, or report attachments. The content clearly fits the category of announcements about changes in the company's board or senior management.
2023-08-03 English
Pursuant to Reg. 30 of the SEBI Listing Regulations, we wish to inform you that Mr. Gaurav Bahadur, People India Director, resigned from the Company with effect from the close of business ....
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding a change in senior management, specifically the resignation of a senior management personnel. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in management. The content includes details about the resignation date and mentions the process of filling the vacancy. There are no financial statements, earnings data, or other report contents. The document is clearly an announcement of a management change rather than a financial report or other filing type.
2023-08-03 English
Board Meeting — SANOFI INDIA LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2023-07-26 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter dated 26th July 2023 from Sanofi India Limited addressed to stock exchanges informing about a scheduled Board of Directors meeting on 10th August 2023. The purpose of the meeting is to consider unaudited financial results for the quarter and half year ended 30th June 2023. It also mentions the closure of the trading window for designated persons. The document is a notification about an upcoming board meeting and financial results consideration, not the financial results report itself. It is a regulatory announcement related to board meeting scheduling and compliance with trading regulations. The document length is short (1855 characters) and does not contain actual financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Annual Report (10-K).
2023-07-26 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve unaudited financial results for ....
Board/Management Information Classification · 95% confidence The document is a letter dated 26th July 2023 from Sanofi India Limited addressed to stock exchanges informing about a forthcoming Board of Directors meeting scheduled for 10th August 2023. The purpose of the meeting is to consider unaudited financial results for the quarter and half year ended 30th June 2023. The letter also mentions the closure of the trading window in relation to the publication of these financial results. The document is a notification about a board meeting and related compliance matters, not the financial results themselves or any detailed report. It is a regulatory announcement about a board meeting date and trading window closure, which fits best under Board/Management Information (MANG). The document length is short and does not contain financial data or detailed report content, so it is not an Interim Report or Earnings Release. Therefore, the classification is MANG with high confidence.
2023-07-26 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges about the resignation of a Non-Executive Director, Ms. Annapurna Das, from the company's Board of Directors. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events including changes in board composition. The content includes the resignation letter and details about the cessation date and reason for resignation. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a board/management change rather than a full report or financial filing. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct disclosure, not a report publication announcement or regulatory filing. Confidence is high due to explicit references and content.
2023-07-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.